Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis
- 25 July 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (15) , 7289-7301
Abstract
Osteoporosis is predominantly treated with drugs that inhibit further bone resorption due to estrogen deficiency. Yet, osteoporosis drugs that not only inhibit bone resorption but also stimulate bone formation, such as potentially inhibitors of 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2), may be more efficacious in the treatment of osteoporosis. Blockade of 17β-HSD2 is thought to increase intracellular estradiol and testosterone in bone, thereby inhibiting bone resorption by osteoclasts and stimulating bone formation by osteoblasts, respectively. We here describe the design, synthesis, and biological characterization of a novel bicyclic-substituted hydroxyphenylmethanone 17β-HSD2 inhibitor (compound 24). Compound 24 is a nanomolar potent inhibitor of human 17β-HSD2 (IC50 of 6.1 nM) and rodent 17β-HSD2 with low in vitro cellular toxicity, devoid of detectable estrogen receptor α affinity, displays high aqueous solubility and in vitro metabolic stability, and has an excellent oral pharmacokinetic profile for testing in a rat osteoporosis model. Administration of 24 in a rat osteoporosis model demonstrates its bone-sparing efficacy.Keywords
Funding Information
- Bundesministerium f?r Bildung und Forschung (031A467)
- Deutsche Forschungsgemeinschaft (Vo410/16-1, Ha1315/16-1)
This publication has 33 references indexed in Scilit:
- A less stressful alternative to oral gavage for pharmacological and toxicological studies in miceToxicology and Applied Pharmacology, 2012
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKLJournal of Bone and Mineral Research, 2009
- Estrogen receptor isoform‐specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβJournal of Cellular Biochemistry, 2003
- Purification, Reconstitution, and Steady-state Kinetics of the Trans-membrane 17β-Hydroxysteroid Dehydrogenase 2Journal of Biological Chemistry, 2002
- Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly menJournal of Clinical Investigation, 2000
- Activity and gene expression of 17β-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8The Journal of Steroid Biochemistry and Molecular Biology, 1998
- 17β-Hydroxysteroid Dehydrogenases in Human Bone CellsJournal of Bone and Mineral Research, 1998
- Characterization of Aromatase and 17β-Hydroxysteroid Dehydrogenase Expression in Rat Osteoblastic CellsJournal of Bone and Mineral Research, 1998
- Estrogen synthesis by osteoblast cell linesEndocrinology, 1992
- Androgen treatment prevents loss of cancellous bone in the orchidectomized ratJournal of Bone and Mineral Research, 1991